Breast Implants and Cancer: The Allergan Case
Published : 2020-01-10 - Categories : Our news
Widely used in cosmetic surgery, breast implants or prostheses add volume to the nipples. Wearing breast prosthesis is also very popular amongst women who have undergone breast amputation. Often bringing about much discomfort, this accessory can cause inflammation and pain in the chest area. Very recently researchers have found out that breast implants are also responsible for the development of lymphatic cancer.
The Allergan case
Research conducted by the ANSM (French National Agency for Medicines and Health Products Safety) has confirmed that Allergan's Biocell and Microcell textured surface breast prosthesis type was responsible for the formation of anaplastic large cell lymphoma (a rare and aggressive cancer of the lymphatic system).
The results of the studies are clear, only people with these implants are affected by anaplastic large cell lymphoma. The number of women affected is significant. There have been deaths. From 2011 to 2019, more than 50 cases of anaplastic large cell lymphoma have been observed in France. More than 100 cases have been observed in CANADA. Two deaths have even been reported.
An irrevocable decision
France and CANADA have banned the marketing and importation of Allergan's textured surface breast prosthesis. The ANSM has ordered Allergan management to withdraw this health threatening product from the market. Quebec health care facilities have sent health alerts to more than 7,000 women in CANADA. They have been urged to contact their surgeons to find out what type of implant they are wearing in order to take appropriate actions.
Prevention is always better than cure. It is always better to live than to die. This is a universal truth no matter where we are. Cancer all ,concerned!
(Photo by Victoria Strukovskaya on Unsplash)